North America Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile based Applications, Sensors, and Other Type), By Clinical Practice, By End Use, By Country and Growth Forecast, 2024 - 2031

The North America Psychiatric Digital Biomarkers Market would witness market growth of 23.5% CAGR during the forecast period (2024-2031).

The US market dominated the North America Psychiatric Digital Biomarkers Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,015.2 million by 2031. The Canada market is expected to witness a CAGR of 26.2% during (2024 - 2031). Additionally, The Mexico market would register a CAGR of 25.1% during (2024 - 2031).

Psychiatric digital biomarkers are objective, quantifiable physiological, behavioral, or digital data points that can be collected and analyzed to assess an individual's mental health. They are derived from digital devices, such as smartphones, wearables, or other connected technologies, and they offer insights into mental health conditions such as schizophrenia, anxiety, bipolar disorder, and melancholy. These biomarkers are revolutionizing mental health care by enabling real-time monitoring, early detection, and personalized treatment of psychiatric disorders. The psychiatric digital biomarkers market is emerging as a transformative frontier in mental health care, addressing longstanding challenges in the diagnosis, treatment, and monitoring of psychiatric disorders.

Digital biomarkers are quantifiable physiological or behavioral data collected through digital devices such as smartphones, wearables, or other connected technologies. In psychiatry, these biomarkers include heart rate variability, sleep patterns, physical activity levels, speech patterns, facial expressions, and social media behavior. These data points, often collected continuously and in real-time, provide a comprehensive view of an individual’s mental state that traditional clinical observations may miss. By leveraging advanced analytics, including artificial intelligence (AI) and machine learning (ML), these biomarkers can detect subtle changes in mental health status, predict the onset of disorders, and monitor treatment efficacy with unprecedented precision.

The Pan American Health Organization (PAHO) highlights in its Mental Health Profile report that mental, neurological, and substance use disorders, along with suicide (MNSS), collectively account for 19% of all disability-adjusted life years (DALYs) and 34% of all years lived with disability in Mexico. The report reveals gender disparities, with alcohol use disorders, headaches, and Alzheimer's disease disproportionately affecting men, while depressive disorders, dementias, headaches, and Alzheimer's disease impact women more severely.

These statistics underscore the critical need for innovative psychiatric digital biomarkers to facilitate early identification and intervention for mental health conditions. By enabling timely and precise screening, these tools can significantly enhance access to appropriate care and support, addressing the region’s unmet mental health care needs. As a result, North America is poised to offer substantial growth opportunities for the psychiatric digital biomarkers market.

Free Valuable Insights: The Psychiatric Digital Biomarkers Market is Predict to reach USD 2.78 Billion by 2031, at a CAGR of 24.1%

Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors, and Other Type. Based on Clinical Practice, the market is segmented into Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers, and Other Clinical Practice. Based on End Use, the market is segmented into Healthcare Companies, Healthcare Providers, Payers, and Other End Use. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Canary Speech, Inc
• Sonde Health, Inc. (Puretech Health Plc)
• Koneksa Health Inc.
• Empatica Inc.
• VivoSense, Inc.
• IXICO Plc
• Neurotrack Technologies, Inc.
• Winterlight Labs
• Aural Analytics, Inc. (Linus Health)

North America Psychiatric Digital Biomarkers Market Report Segmentation

By Type

• Wearable
• Mobile based Applications
• Sensors
• Other Type

By Clinical Practice

• Diagnostic Psychiatric Digital Biomarkers
• Monitoring Psychiatric Digital Biomarkers
• Predictive and Prognostic Psychiatric Digital Biomarkers
• Other Clinical Practice

By End Use

• Healthcare Companies
• Healthcare Providers
• Payers
• Other End Use

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Psychiatric Digital Biomarkers Market, by Type
1.4.2 North America Psychiatric Digital Biomarkers Market, by Clinical Practice
1.4.3 North America Psychiatric Digital Biomarkers Market, by End Use
1.4.4 North America Psychiatric Digital Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Psychiatric Digital Biomarkers Market by Type
4.1 North America Wearable Market by Country
4.2 North America Mobile based Applications Market by Country
4.3 North America Sensors Market by Country
4.4 North America Other Type Market by Country

Chapter 5. North America Psychiatric Digital Biomarkers Market by Clinical Practice
5.1 North America Diagnostic Psychiatric Digital Biomarkers Market by Country
5.2 North America Monitoring Psychiatric Digital Biomarkers Market by Country
5.3 North America Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country
5.4 North America Other Clinical Practice Market by Country

Chapter 6. North America Psychiatric Digital Biomarkers Market by End Use
6.1 North America Healthcare Companies Market by Country
6.2 North America Healthcare Providers Market by Country
6.3 North America Payers Market by Country
6.4 North America Other End Use Market by Country

Chapter 7. North America Psychiatric Digital Biomarkers Market by Country
7.1 US Psychiatric Digital Biomarkers Market
7.1.1 US Psychiatric Digital Biomarkers Market by Type
7.1.2 US Psychiatric Digital Biomarkers Market by Clinical Practice
7.1.3 US Psychiatric Digital Biomarkers Market by End Use
7.2 Canada Psychiatric Digital Biomarkers Market
7.2.1 Canada Psychiatric Digital Biomarkers Market by Type
7.2.2 Canada Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.3 Canada Psychiatric Digital Biomarkers Market by End Use
7.3 Mexico Psychiatric Digital Biomarkers Market
7.3.1 Mexico Psychiatric Digital Biomarkers Market by Type
7.3.2 Mexico Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.3 Mexico Psychiatric Digital Biomarkers Market by End Use
7.4 Rest of North America Psychiatric Digital Biomarkers Market
7.4.1 Rest of North America Psychiatric Digital Biomarkers Market by Type
7.4.2 Rest of North America Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.3 Rest of North America Psychiatric Digital Biomarkers Market by End Use

Chapter 8. Company Profiles
8.1 Canary Speech, Inc.
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Sonde Health, Inc. (Puretech Health Plc)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.2.5 SWOT Analysis
8.3 Koneksa Health Inc.
8.3.1 Company Overview
8.4 Empatica Inc.
8.4.1 Company Overview
8.5 VivoSense, Inc.
8.5.1 Company Overview
8.6 IXICO plc
8.6.1 Company Overview
8.7 Neurotrack Technologies, Inc.
8.7.1 Company Overview
8.8 WinterLight Labs
8.8.1 Company Overview
8.9 Aural Analytics, Inc. (Linus Health)
8.9.1 Company Overview

TABLE 1 North America Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 2 North America Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 3 North America Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 4 North America Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 5 North America Wearable Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Wearable Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Mobile based Applications Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Mobile based Applications Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Sensors Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Sensors Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Other Type Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Other Type Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 14 North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 15 North America Diagnostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Diagnostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Monitoring Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Monitoring Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Other Clinical Practice Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Other Clinical Practice Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 24 North America Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 25 North America Healthcare Companies Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Healthcare Companies Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Healthcare Providers Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Healthcare Providers Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Payers Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Payers Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 35 US Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 36 US Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 37 US Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 38 US Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 39 US Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 40 US Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 41 US Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 42 US Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 43 Canada Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 44 Canada Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 45 Canada Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 46 Canada Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 47 Canada Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 48 Canada Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 49 Canada Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 50 Canada Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 51 Mexico Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 52 Mexico Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 53 Mexico Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 54 Mexico Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 55 Mexico Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 56 Mexico Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 57 Mexico Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 58 Mexico Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 59 Rest of North America Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 60 Rest of North America Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 61 Rest of North America Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 62 Rest of North America Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 63 Rest of North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 64 Rest of North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 65 Rest of North America Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 66 Rest of North America Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 67 Key Information – Canary Speech, Inc.
TABLE 68 Key Information – Sonde Health, Inc.
TABLE 69 Key Information – Koneksa Health Inc.
TABLE 70 Key Information – Empatica Inc.
TABLE 71 Key Information – VivoSense, Inc.
TABLE 72 Key Information – IXICO plc
TABLE 73 Key Information – Neurotrack Technologies, Inc.
TABLE 74 Key Information – WinterLight Labs
TABLE 75 Key Information – Aural Analytics, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Psychiatric Digital Biomarkers Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Psychiatric Digital Biomarkers Market
FIG 4 Porter’s Five Forces Analysis – Psychiatric Digital Biomarkers Market
FIG 5 North America Psychiatric Digital Biomarkers Market share by Type, 2023
FIG 6 North America Psychiatric Digital Biomarkers Market share by Type, 2031
FIG 7 North America Psychiatric Digital Biomarkers Market by Type, 2020 - 2031, USD Million
FIG 8 North America Psychiatric Digital Biomarkers Market share by Clinical Practice, 2023
FIG 9 North America Psychiatric Digital Biomarkers Market share by Clinical Practice, 2031
FIG 10 North America Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2031, USD Million
FIG 11 North America Psychiatric Digital Biomarkers Market share by End Use, 2023
FIG 12 North America Psychiatric Digital Biomarkers Market share by End Use, 2031
FIG 13 North America Psychiatric Digital Biomarkers Market by End Use, 2020 - 2031, USD Million
FIG 14 North America Psychiatric Digital Biomarkers Market share by Country, 2023
FIG 15 North America Psychiatric Digital Biomarkers Market share by Country, 2031
FIG 16 North America Psychiatric Digital Biomarkers Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Canary Speech, Inc.
FIG 18 Recent strategies and developments: Sonde Health, Inc.
FIG 19 SWOT Analysis: Sonde Health, Inc.